TGFB1 and cancer: Although deregulated activation of both β-catenin and TGF-β signalling cascades have been implicated in NSCLC, the molecular basis for such deregulation remains puzzling as genetic mutations of core components in the pathways are rare, unlike in other cancer types41, 42.